Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Lowered to $860 at Wolfe Research

May 18, 2026 3:46 PM
Wolfe Research analyst Alexandria Hammond lowered the price target on Regeneron Pharma (NASDAQ: REGN) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change